Close Menu

This story has been updated from a previous version to include comments made by Qiagen CEO Thierry Bernard in an earnings call.

NEW YORK – Qiagen reported on Tuesday afternoon that its third quarter revenues increased 26 percent year over year, prompting the firm to adjust its full-year financial outlook upwards.

Qiagen released its Q3 financial results a little more than a week ahead of the originally planned date of Nov. 4.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.